Company intelligence / Profile preview

Ephemeral Solutions

New York City, New York, United Statesephemeral.tattoo ↗

Ownership: Private
Development stage: Commercial

Overview

Ephemeral developed a proprietary tattoo ink designed to fade completely after about one year. The technology uses encapsulated dye molecules that can be broken down by an external removal solution or naturally over time. Early testing included in vitro and animal studies for safety and efficacy; human use was planned pending further validation.

Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships reported; focus on direct-to-consumer model with pre-approved artists.

Beyond the preview

Go deeper on Ephemeral Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ephemeral Solutions.

Explore the full profile